Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1G93A) transgenic amyotrophic lateral sclerosis (ALS) mice

被引:8
|
作者
Lee, Jae Chul [1 ]
Jin, Younggeon [2 ,3 ]
Jin, Juyoun [2 ,3 ]
Kang, Bong Gu [2 ,3 ]
Nam, Do-Hyun [2 ,3 ]
Joo, Kyeung Min [1 ]
Cha, Choong Ik [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110799, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Amyotrophic lateral sclerosis; In vitro expansion; Mutant SOD1 transgenic mouse; Neural stem cell; Hippocampus; Primary culture; SUPEROXIDE-DISMUTASE; MOTOR-NEURONS; DISEASE; NEUROGENESIS; DEGENERATION; MODEL; PROLIFERATION; PROGRESSION; MICROGLIA; SURVIVAL;
D O I
10.1179/016164110X12807570509899
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: The aim of present study is to investigate more functional neural stem cells (NSCs) could be isolated from brains with amyotrophic lateral sclerosis (ALS) and expanded in vitro, based on previous reports demonstrating de novo neurogenesis is enhanced to replace degenerating neural tissue. Methods: Thirteen-or eighteen-week-old mutant human Cu/Zn superoxide dismutase (SOD1(G93A)) transgenic ALS and wild-type SOD1 transgenic control mice were utilized. Changes in numbers of NSCs in the dentate gyrus were analyzed by immunohistochemistry against nestin and CD133. NSCs were primarily cultured from hippocampus of ALS or control mice. Expression of NSC markers, in vitro expansion capacity, and differentiating potential were compared. Results: Hippocampus of 13-week-old pre-symptomatic ALS mice harbor more cells that can be propagated for more than 12 passages in vitro, compared with same age control mice. Primarily-cultured cells formed neurospheres in the NSC culture medium, expressed NSC markers, and differentiated into cells with differentiated neural cell characteristics in the differentiation condition confirming that they are NSCs. In contrast, long-term expansible NSCs could not be derived from brains of 18-week-old symptomatic ALS mice with the same experimental techniques, although they had comparable nestin-immunoreactive cells in the dentate gyrus. Discussion: These results would suggest that increased neuroregeneration in early phase of ALS could be translated to regenerative approaches; however, long-term exposure to ALS microenvironments could abolish functional capacities of NSCs.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 50 条
  • [1] Analysis of Feeding Behavior Characteristics in the Cu/Zn Superoxide Dismutase 1 (SOD1) SOD1G93A Mice Model for Amyotrophic Lateral Sclerosis (ALS)
    Kitaoka, Yoshihiro
    Seki, Soju
    Kawata, Sou
    Nishiura, Akira
    Kawamura, Kohei
    Hiraoka, Shin-ichiro
    Kogo, Mikihiko
    Tanaka, Susumu
    NUTRIENTS, 2023, 15 (07)
  • [2] Erythropoietin modulates the immune-inflammatory response of a SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS)
    Noh, Min Young
    Cho, Kyung Ah
    Kim, Heejaung
    Kim, Sung-Min
    Kim, Seung Hyun
    NEUROSCIENCE LETTERS, 2014, 574 : 53 - 58
  • [3] Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis
    Kaur, Simran J.
    McKeown, Stephanie R.
    Rashid, Shazia
    GENE, 2016, 577 (02) : 109 - 118
  • [4] Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice
    Peviani, M.
    Caron, I.
    Pizzasegola, C.
    Gensano, F.
    Tortarolo, M.
    Bendotti, C.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (04) : 491 - 503
  • [5] Argonaute 2 is lost from neuromuscular junctions affected with amyotrophic lateral sclerosis in SOD1G93A mice
    Shapiro, Dillon
    Massopust, Ryan
    Taetzsch, Thomas
    Valdez, Gregorio
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1(G93A) mice
    Scaricamazza, Silvia
    Salvatori, Illari
    Amadio, Susanna
    Nesci, Valentina
    Torcinaro, Alessio
    Giacovazzo, Giacomo
    Primiano, Aniello
    Gloriani, Michela
    Candelise, Niccolo
    Pieroni, Luisa
    Loeffler, Jean-Philippe
    Rene, Frederique
    Quessada, Cyril
    Tefera, Tesfaye W.
    Wang, Hao
    Steyn, Frederik J.
    Ngo, Shyuan T.
    Dobrowolny, Gabriella
    Lepore, Elisa
    Urbani, Andrea
    Musaro, Antonio
    Volonte, Cinzia
    Ferraro, Elisabetta
    Coccurello, Roberto
    Valle, Cristiana
    Ferri, Alberto
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (08) : 1732 - 1752
  • [7] Optimised and Rapid Pre-clinical Screening in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
    Mead, Richard J.
    Bennett, Ellen J.
    Kennerley, Aneurin J.
    Sharp, Paul
    Sunyach, Claire
    Kasher, Paul
    Berwick, Jason
    Pettmann, Brigitte
    Battaglia, Guiseppe
    Azzouz, Mimoun
    Grierson, Andrew
    Shaw, Pamela J.
    PLOS ONE, 2011, 6 (08):
  • [8] ADVERSE EFFECTS OF A SOD1-PEPTIDE IMMUNOTHERAPY ON SOD1G93A MOUSE SLOW MODEL OF AMYOTROPHIC LATERAL SCLEROSIS
    Sabado, J.
    Casanovas, A.
    Rodrigo, H.
    Arque, G.
    Esquerda, J. E.
    NEUROSCIENCE, 2015, 310 : 38 - 50
  • [9] Prevention of Motor Neuron Degeneration by Novel Iron Chelators in SOD1G93A Transgenic Mice of Amyotrophic Lateral Sclerosis
    Wang, Qian
    Zhang, Xiaojie
    Chen, Sheng
    Zhang, Xin
    Zhang, Sufang
    Youdium, Moussa
    Le, Weidong
    NEURODEGENERATIVE DISEASES, 2011, 8 (05) : 310 - 321
  • [10] Genetic Biomarkers for ALS Disease in Transgenic SOD1G93A Mice
    Calvo, Ana C.
    Manzano, Raquel
    Atencia-Cibreiro, Gabriela
    Olivan, Sara
    Munoz, Maria J.
    Zaragoza, Pilar
    Cordero-Vazquez, Pilar
    Esteban-Perez, Jesus
    Garcia-Redondo, Alberto
    Osta, Rosario
    PLOS ONE, 2012, 7 (03):